Bentham Science Logo

Track Your Manuscript:

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research


Cardiovascular & Hematological Disorders-Drug Targets , Volume 15 - Number 2

Rationale for Development of New Oral Anticoagulants

, 15(2): 89 - 91

Muharrem Akin, Julian Widder, Ibrahim Akin, Michael Brehm and Andreas Schäfer

DOI: 10.2174/1871529X1502151209110044

New Oral Anticoagulants in Coronary Artery Disease

, 15(2): 101 - 105

Michael Behnes, Christian Fastner, Uzair Ansari and Ibrahim Akin

DOI: 10.2174/1871529X1502151209111429

New Oral Anticoagulation after Heart Valve Replacement

, 15(2): 106 - 109

Ibrahim El-Battrawy, Stefan Baumann, Aydin Huseynov and Ibrahim Akin

DOI: 10.2174/1871529X1502151209111735

Novel Oral Anticoagulation During Pulmonary Vein Isolation and Cardioversion

, 15(2): 110 - 114

Christian Fastner, Michael Behnes, Uzair Ansari and Ibrahim Akin

DOI: 10.2174/1871529X1502151209112128

Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications

, 15(2): 115 - 119

Aydin Huseynov, Stefan Baumann, Ibrahim El-Battrawy and Ibrahim Akin

DOI: 10.2174/1871529X1502151209112437

Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases

, 15(2): 127 - 138

Velio Bocci, Iacopo Zanardia, Giuseppe Valacchi, Emma Borrelli and Valter Travagli

DOI: 10.2174/1871529X1502151209114642

Apixaban in Venous Thromboembolism in an Era of New Oral Anticoagulants

, 15(2): 139 - 147

Mohit K. Turagam, Poonam Velagapudi, Oluwaseun Adeola, Bhavana Chinnakotla and Martin A. Alpert

DOI: 10.2174/1871529X1502151209120216

Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes

, 15(2): 148 - 161

Evgenia Verigou, Polixeni Lampropoulou, Nikoletta Smyrni, Georgia Kolliopoulou, George Sakellaropoulos, Ioannis Starakis, Panagiotis Zikos, Elena Solomou, Argiris Symeonidis and Marina Karakantza

DOI: 10.2174/1871529X15666150701105822


Garry X. Shen
University of Manitoba
Winnipeg, MB

View Full Editorial Board

COPE Compliant

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology

You can view the contents of this eBook [here] or purchase it [here].


How to write and publish your papers in high impact journalsPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog